The most effective probiotics for bacterial vaginosis (BV) are specific strains of Lactobacillus, particularly L. crispatus, L. rhamnosus, and L. reuteri. These aren’t interchangeable with a generic grocery-store yogurt supplement. The strain matters, the dose matters, and how you use them alongside standard antibiotic treatment matters.
That said, probiotics are not a replacement for antibiotics when it comes to active BV. The CDC’s current treatment guidelines state that no probiotic has enough evidence to be recommended as a standalone or even adjunctive therapy. What the clinical research does show is that certain strains can help restore healthy vaginal flora and reduce the frustratingly high recurrence rate that follows antibiotic treatment.
The Strains With the Strongest Evidence
Not all Lactobacillus strains do the same thing. The ones worth paying attention to have been tested in human trials specifically for BV, not just general “gut health.”
- Lactobacillus crispatus CTV-05 (Lactin-V): This is the strain with the most rigorous evidence behind it. A randomized trial published in the New England Journal of Medicine tested it in 228 women who had just completed a course of vaginal metronidazole for BV. Women who used Lactin-V vaginally for 11 weeks had a 30% recurrence rate by week 12, compared to 45% in the placebo group. That’s roughly a one-third reduction in the chance of BV coming back. By week 24, the benefit held up. The strain was still detectable in 79% of the women who used it, meaning it successfully colonized. Lactin-V is not yet widely available as an over-the-counter product, but L. crispatus is the dominant species in a healthy vaginal microbiome, which is why researchers have focused on it.
- Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: These two strains are the most thoroughly studied oral vaginal probiotics and are often found together in commercial supplements. Taken orally for 30 days, they’ve been shown to notably improve vaginal flora in BV patients. However, when used as an add-on to metronidazole, one trial found no significant difference in total cure rate compared to antibiotics alone. Their strength appears to be in shifting vaginal bacteria in a healthier direction rather than curing an active infection.
- Lactobacillus rhamnosus TOM 22.8: A systematic review identified this as the most effective single strain and dose combination, with 10 billion CFU per day taken orally for 10 days. It improved Nugent scores (a lab measure of vaginal bacterial balance) in 96.7% of participants after 10 days, and the improvement held at 30 days. It also reduced vaginal pH and lowered recurrence rates.
Other strains that showed therapeutic potential in the same review include L. plantarum and L. acidophilus, though the evidence for them is thinner.
How Probiotics Work Against BV
A healthy vagina is dominated by Lactobacillus bacteria, which produce lactic acid and keep the environment acidic (around pH 3.8 to 4.5). BV happens when that Lactobacillus population drops and gets replaced by a mix of other bacteria, raising the pH and causing the characteristic discharge and odor.
Probiotic Lactobacillus strains work by re-establishing that acidic environment. They produce lactic acid, compete with harmful bacteria for space and nutrients, and reduce the populations of problematic species. In one study of pregnant women, taking L. rhamnosus and L. reuteri capsules significantly decreased levels of Staphylococcus, Streptococcus, and Enterococcus in the vaginal flora. The goal is essentially to crowd out the bacteria causing BV and restore the conditions that keep them from coming back.
Dose and Duration
Across clinical trials, effective doses ranged widely, from 100 million to 30 billion CFU per day. The sweet spot in most successful trials was between 1 billion and 10 billion CFU daily. Treatment durations ranged from 6 days to 4 months, depending on the strain and whether the goal was treating active BV or preventing recurrence.
The strongest single result came from L. rhamnosus TOM 22.8 at 10 billion CFU per day for 10 days. For the L. crispatus CTV-05 trial, women used the vaginal product for 11 weeks. If you’re choosing an over-the-counter supplement, look for one that lists specific strain names (not just “Lactobacillus blend”) and provides at least 1 billion CFU per dose.
Oral Capsules vs. Vaginal Suppositories
You might assume vaginal probiotics would work better since BV is a vaginal condition. The research suggests it doesn’t matter much. A clinical trial comparing oral and vaginal probiotics after metronidazole treatment found both routes brought Nugent scores down from the BV range (8.5 to 9) to a healthy range (around 3), with no statistically significant difference between them. Both groups showed significant improvement from baseline.
This means you can choose based on what you’re more comfortable with. Oral capsules are simpler and feel more like taking a regular supplement. Vaginal suppositories deliver bacteria directly to the site but require more effort. If compliance is the concern, oral is the easier option.
Timing With Antibiotics
If you’re taking metronidazole or another antibiotic for BV, timing your probiotic dose matters. Most Lactobacillus strains are sensitive to antibiotics, so taking them at the same time can kill the probiotic bacteria before they do anything useful. The International Scientific Association for Probiotics and Prebiotics recommends spacing probiotics at least 2 hours away from your antibiotic dose.
Some women start probiotics during their antibiotic course, while others wait until after completing it. The Lactin-V trial, which showed the clearest benefit, started the probiotic after women finished their metronidazole course. A meta-analysis of multiple trials found that probiotic-only therapy (used after or instead of antibiotics) resulted in clinical cure rates 2.5 times higher than placebo at 30 days and significantly improved Nugent scores.
What to Expect Realistically
Probiotics are not a quick fix for BV, and they work better as a follow-up strategy than a first-line treatment. The most impressive result in the research, from the Lactin-V trial, still saw 30% of women experience recurrence. That’s better than the 45% recurrence in the placebo group, but it’s not a guarantee. BV has a recurrence rate of roughly 50% within 12 months after standard antibiotic treatment, which is why the probiotic research focuses so heavily on prevention rather than cure.
Side effects from probiotics are generally minor in healthy people. Reported concerns include mild digestive changes with oral capsules and occasional irritation with vaginal products. Women with compromised immune systems or serious underlying illnesses face a higher risk of adverse effects, including rare infections. For most women, though, the safety profile is reassuring.
Choosing a Product
When shopping for a probiotic for BV, look for these specifics on the label:
- Named strains: The label should list strain-level identifiers (like L. rhamnosus GR-1), not just species names. A product that says “Lactobacillus blend” without strain details gives you no way to match it to clinical evidence.
- CFU count: At least 1 billion CFU, ideally closer to 10 billion for strains with dose-specific evidence.
- Strains studied for vaginal health: L. crispatus, L. rhamnosus, and L. reuteri are the most relevant. Many probiotic products are formulated for gut health and contain strains with no vaginal research behind them.
Probiotics are classified as supplements, not drugs, so they don’t undergo the same regulatory scrutiny as prescription treatments. Quality varies between manufacturers. Choosing products from companies that participate in third-party testing can reduce the risk of getting a product with fewer live bacteria than advertised or unlisted ingredients.